Novo Nordisk has agreed to pay $25 million to settle the fraud case our clients filed against the company. As set out in the Complaint, Novo Nordisk aggressively marketed NovoSeven for unapproved uses to the military. Those off label uses subjected soldiers to potentially deadly side effects, and cost taxpayers millions of dollars in false claims. More to come . . . .